Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Panacea Biotec Limited
  6. News
  7. Summary
    531349   INE922B01023

PANACEA BIOTEC LIMITED

(531349)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Panacea Biotec : India's Panacea Biotec to produce 100 million Sputnik V doses annually - RDIF

04/05/2021 | 08:12am EDT
A vial with Russia's Sputnik V coronavirus disease (COVID-19) vaccine is seen before being administered, at a private hospital in Karachi

MOSCOW (Reuters) - Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.

RDIF did not say when production would begin.

(Reporting by Vladimir Soldatkin; Writing by Alexander Marrow, ediitng by Emelia Sithole-Matarise)


© Reuters 2021
All news about PANACEA BIOTEC LIMITED
06/03PANACEA BIOTEC  : Narrows Loss in Q4
MT
05/24PANACEA BIOTEC  : Russian Fund Begin Production of Sputnik COVID-19 Vaccine in I..
MT
05/24Indian shares close higher as financials gain, COVID-19 cases fall
RE
05/17PANACEA BIOTEC  : Sues Sanofi Healthcare India Over Vaccine Patent Infringement
MT
04/05PANACEA BIOTEC  : Ties Up With Russian Fund to Produce 100 Million Doses of COVI..
MT
04/05PANACEA BIOTEC  : Russia signs deal with India to produce 100 million Sputnik V ..
AQ
04/05PANACEA BIOTEC  : India's Panacea Biotec to produce 100 million Sputnik V doses ..
RE
2020PANACEA BIOTEC  : Biotech Subsidiary Encounters a Minor Fire Incident at Baddi F..
MT
2020PANACEA BIOTEC LIMITED : Spin off
FA
2020Indian drugmaker Biological E. to make substance used in J&J's potential COVI..
RE
More news
Financials
Sales 2021 6 248 M 84,1 M 84,1 M
Net income 2021 -1 477 M -19,9 M -19,9 M
Net Debt 2021 7 043 M 94,8 M 94,8 M
P/E ratio 2021 -7,36x
Yield 2021 -
Capitalization 23 490 M 316 M 316 M
EV / Sales 2020 2,52x
EV / Sales 2021 2,87x
Nbr of Employees 2 338
Free-Float 12,7%
Chart PANACEA BIOTEC LIMITED
Duration : Period :
Panacea Biotec Limited Technical Analysis Chart | 531349 | INE922B01023 | MarketScreener
Technical analysis trends PANACEA BIOTEC LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
NameTitle
Rajesh Jain Managing Director & Executive Director
Sandeep Jain Joint Managing Director & Executive Director
Vinod Goel Group CFO, Secretary & Compliance Officer
Devender Gupta CFO & Head-Information Technology
Soshil Kumar Jain Chairman